Di Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Di Chen has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
Qizhe Shao
Center for Regeneration and Cell Therapy of Zhejiang University–University of Edinburgh Institute (ZJU–UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Haining, China
6 shared publicationsZiqi Wang
Center for Reproductive Medicine of The Second Affiliated Hospital, Center for Regeneration and Cell Therapy of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
6 shared publicationsLingling Tong
Center for Reproductive Medicine of The Second Affiliated Hospital, Center for Regeneration and Cell Therapy of Zhejiang, University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
5 shared publicationsJin Zhang
Center for Regeneration and Cell Therapy of Zhejiang University, Center for Reproductive Medicine of The Second Affiliated Hospital, University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
4 shared publications- Min Jin
Zhejiang University School of Medicine, Zhejiang University Center for Reproductive Medicine of The Second Affiliated Hospital Hangzhou 310003
4 shared publications Yaxuan Ye
Center for Reproductive Medicine of The Second Affiliated Hospital, Center for Regeneration and Cell Therapy of Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China
4 shared publications
Latest Publications
- 19 October 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (11) , 2845-2858
Establishing Polycomb regulatory landscapes in human early development
- 19 October 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (11) , 2845-2858
Establishing Polycomb regulatory landscapes in human early development
- Open Access
- 31 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Functional Characterization of RNA Profiles in Processing Bodies of Embryonic Stem Cells and Mesodermal Cells
Processing bodies (P-bodies) are membraneless organelles that exist in eukaryotic cells, contributing to the post-transcriptional regulation of gene expression. Abnormalities in P-bodies lead to diseases and developmental disorders. Recent studies have demonstrated the involvement of P-bodies in stem cell fate regulation by associating the depletion of P-bodies with cell fate change. However, how the dynamics of RNA components in different cell types are related to corresponding cell fates remains poorly understood. Here, we systematically characterized the RNA profiles of P-bodies from HEK293T cells, human embryonic stem cells (hESCs), and hESC-derived mesodermal cells. By functional analysis of the P-body-enriched and P-body-depleted RNAs across different developmental stages, we discovered the cell type-specific enrichment of P-body RNAs. We also captured the non-coding RNAs, including long intergenic non-coding RNAs and transposable elements in P-bodies in a cell type-specific manner. Furthermore, we verified the functions of P-bodies in regulating the differentiation of hESCs toward mesodermal cell fate by over-expressing LSM14A, one of the key P-body protein components, and knocking down SPTAN1, one of the P-body-enriched mRNAs. In summary, we characterized the mRNAs and non-coding RNAs in P-bodies from HEK293T, hESCs and hESC-derived mesodermal cells, deciphering the potential developmental roles of P-bodies in the maintenance and differentiation of hESCs.
- 31 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessFunctional Characterization of RNA Profiles in Processing Bodies of Embryonic Stem Cells and Mesodermal Cells
Processing bodies (P-bodies) are membraneless organelles that exist in eukaryotic cells, contributing to the post-transcriptional regulation of gene expression. Abnormalities in P-bodies lead to diseases and developmental disorders. Recent studies have demonstrated the involvement of P-bodies in stem cell fate regulation by associating the depletion of P-bodies with cell fate change. However, how the dynamics of RNA components in different cell types are related to corresponding cell fates remains poorly understood. Here, we systematically characterized the RNA profiles of P-bodies from HEK293T cells, human embryonic stem cells (hESCs), and hESC-derived mesodermal cells. By functional analysis of the P-body-enriched and P-body-depleted RNAs across different developmental stages, we discovered the cell type-specific enrichment of P-body RNAs. We also captured the non-coding RNAs, including long intergenic non-coding RNAs and transposable elements in P-bodies in a cell type-specific manner. Furthermore, we verified the functions of P-bodies in regulating the differentiation of hESCs toward mesodermal cell fate by over-expressing LSM14A, one of the key P-body protein components, and knocking down SPTAN1, one of the P-body-enriched mRNAs. In summary, we characterized the mRNAs and non-coding RNAs in P-bodies from HEK293T, hESCs and hESC-derived mesodermal cells, deciphering the potential developmental roles of P-bodies in the maintenance and differentiation of hESCs.
- Open Access
- 31 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Mapping Allele-specific RBP Binding by a Machine Learning Coupled RNA Editing Strategy in Human Embryonic Stem Cells
RNA-binding proteins (RBPs) play critical roles in regulating the maintenance and differentiation of embryonic stem cells. A critical step in understanding the functions of RBPs is the identification of their bound RNA transcripts. To achieve this, we developed an inducible strategy termed RNA-Editing-Based-RNA-seq (REB-seq) coupled with machine learning to capture the potential RNA targets bound by the RBPs-of-interest. By fusing RBPs to the catalytic domain of ADAR or APOBEC1, which mediates the A-to-I (A-to-G) or C-to-U (C-to-T) editing, respectively, REB-seq enables transcriptome-wide identification of RBP-bound RNAs without high-quality antibodies. Using REB-seq, we characterized the mRNAs bound by the N6-methyladenosine (m6A) readers IGF2BP1, IGF2BP2, and IGF2BP3 in human embryonic stem cells. Coupling REB-seq analysis with machine learning further improves the accuracy of target RNA characterization. Furthermore, REB-seq identifies associated single nucleotide polymorphisms that may affect the RBP binding and imply disease pathogenesis. Collectively, REB-seq coupled with machine learning provides a robust and accessible approach for profiling allele-specific RNA transcripts bound by RBPs-of-interest.
- 31 August 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessMapping Allele-specific RBP Binding by a Machine Learning Coupled RNA Editing Strategy in Human Embryonic Stem Cells
RNA-binding proteins (RBPs) play critical roles in regulating the maintenance and differentiation of embryonic stem cells. A critical step in understanding the functions of RBPs is the identification of their bound RNA transcripts. To achieve this, we developed an inducible strategy termed RNA-Editing-Based-RNA-seq (REB-seq) coupled with machine learning to capture the potential RNA targets bound by the RBPs-of-interest. By fusing RBPs to the catalytic domain of ADAR or APOBEC1, which mediates the A-to-I (A-to-G) or C-to-U (C-to-T) editing, respectively, REB-seq enables transcriptome-wide identification of RBP-bound RNAs without high-quality antibodies. Using REB-seq, we characterized the mRNAs bound by the N6-methyladenosine (m6A) readers IGF2BP1, IGF2BP2, and IGF2BP3 in human embryonic stem cells. Coupling REB-seq analysis with machine learning further improves the accuracy of target RNA characterization. Furthermore, REB-seq identifies associated single nucleotide polymorphisms that may affect the RBP binding and imply disease pathogenesis. Collectively, REB-seq coupled with machine learning provides a robust and accessible approach for profiling allele-specific RNA transcripts bound by RBPs-of-interest.
- Open Access
- 30 July 2026
- Published by Springer Nature in Cell Research
- Vol. 36 (10) , 785-803
TRIM37 interacts with TRIM28 to maintain primordial germ cell identity during migration
During primordial germ cell (PGC) specification, repression of somatic programs is essential for the establishment of germline identity. However, mechanisms that safeguard PGC fate thereafter remain unknown. Here, we identify the E3 ubiquitin ligase TRIM37 as a critical safeguard of PGC fate during migration. Trim37 deficiency causes severe PGC defects beginning at embryonic day 9.5 (E9.5) with complete PGC depletion by E12.5, and leads to an aberrant transition toward somatic cell states. Mechanistically, TRIM37 binds TRIM28 through its MATH domain and ubiquitinates TRIM28 via its RING domain, enhancing the TRIM37–TRIM28 interaction and promoting the nuclear retention of TRIM37. Forced nuclear export of TRIM37 results in PGC loss. Moreover, disruption of TRIM37 ligase activity or mutation of TRIM28 ubiquitination sites compromises PGC maintenance. We further show that the TRIM37–TRIM28 complex, likely acting in cooperation with AP2γ, restricts chromatin accessibility and H3K27ac levels at somatic gene loci, thereby repressing somatic transcriptional programs in PGCs. Together, our findings uncover a TRIM37–TRIM28–AP2γ regulatory complex that safeguards germ cell fate by preventing the activation of somatic transcriptional programs during PGC migration.
- 30 July 2026
- Published by Springer Nature in Cell Research
- Vol. 36 (10) , 785-803
Open AccessTRIM37 interacts with TRIM28 to maintain primordial germ cell identity during migration
During primordial germ cell (PGC) specification, repression of somatic programs is essential for the establishment of germline identity. However, mechanisms that safeguard PGC fate thereafter remain unknown. Here, we identify the E3 ubiquitin ligase TRIM37 as a critical safeguard of PGC fate during migration. Trim37 deficiency causes severe PGC defects beginning at embryonic day 9.5 (E9.5) with complete PGC depletion by E12.5, and leads to an aberrant transition toward somatic cell states. Mechanistically, TRIM37 binds TRIM28 through its MATH domain and ubiquitinates TRIM28 via its RING domain, enhancing the TRIM37–TRIM28 interaction and promoting the nuclear retention of TRIM37. Forced nuclear export of TRIM37 results in PGC loss. Moreover, disruption of TRIM37 ligase activity or mutation of TRIM28 ubiquitination sites compromises PGC maintenance. We further show that the TRIM37–TRIM28 complex, likely acting in cooperation with AP2γ, restricts chromatin accessibility and H3K27ac levels at somatic gene loci, thereby repressing somatic transcriptional programs in PGCs. Together, our findings uncover a TRIM37–TRIM28–AP2γ regulatory complex that safeguards germ cell fate by preventing the activation of somatic transcriptional programs during PGC migration.
- Open Access
- 26 May 2026
- Published by Oxford University Press (OUP) in Life Metabolism
- Vol. 5 (4)
Exercise preserves β-cell function in type 2 diabetes by reshaping intra-islet macrophage–β-cell crosstalk
Type 2 diabetes (T2D) is characterized by pancreatic islet β-cell dysfunction and systemic insulin resistance, with meta-inflammation playing a critical role in disease progression. As the major type of immune cell population in islets, both resident and recruited macrophages are important regulators of the islet immune microenvironment under physiological and T2D conditions. Exercise is an effective strategy for treating T2D, yet its impacts on islet inflammation and β-cell dysfunction remain elusive. Here, we established a mouse model of exercise intervention in obesity-associated T2D by combining high-fat diet (HFD) feeding with treadmill running. Notably, exercise markedly improves glucose tolerance and insulin sensitivity, accompanied by substantial mitigation of HFD-induced β-cell dysfunction, islet hypertrophy, and alterations in β-cell subpopulations. Exercise also reduces intra-islet infiltration of CD45+ immune cells and dampens pro-inflammatory gene expression, indicating robust attenuation of islet inflammation. Using untargeted plasma proteomics, we identified the secreted protein acidic and rich in cysteine (SPARC) as a circulating factor, whose suppression is associated with exercise-linked islet protection under HFD conditions. Mechanistically, our data support a model in which SPARC contributes to β-cell dysfunction, at least in part, through macrophage inflammasome-related signaling. Further analysis of a human cohort demonstrates that circulating SPARC protein levels are markedly elevated in patients with T2D, exhibiting a significant negative correlation with parameters indicative of insulin sensitivity and β-cell function, and a positive correlation with insulin resistance. Together, this work provides a systemic characterization of the effects of exercise intervention on islet homeostasis and β-cell function, and highlights SPARC as a candidate immuno-metabolic node for T2D intervention.
- 26 May 2026
- Published by Oxford University Press (OUP) in Life Metabolism
- Vol. 5 (4)
Open AccessExercise preserves β-cell function in type 2 diabetes by reshaping intra-islet macrophage–β-cell crosstalk
Type 2 diabetes (T2D) is characterized by pancreatic islet β-cell dysfunction and systemic insulin resistance, with meta-inflammation playing a critical role in disease progression. As the major type of immune cell population in islets, both resident and recruited macrophages are important regulators of the islet immune microenvironment under physiological and T2D conditions. Exercise is an effective strategy for treating T2D, yet its impacts on islet inflammation and β-cell dysfunction remain elusive. Here, we established a mouse model of exercise intervention in obesity-associated T2D by combining high-fat diet (HFD) feeding with treadmill running. Notably, exercise markedly improves glucose tolerance and insulin sensitivity, accompanied by substantial mitigation of HFD-induced β-cell dysfunction, islet hypertrophy, and alterations in β-cell subpopulations. Exercise also reduces intra-islet infiltration of CD45+ immune cells and dampens pro-inflammatory gene expression, indicating robust attenuation of islet inflammation. Using untargeted plasma proteomics, we identified the secreted protein acidic and rich in cysteine (SPARC) as a circulating factor, whose suppression is associated with exercise-linked islet protection under HFD conditions. Mechanistically, our data support a model in which SPARC contributes to β-cell dysfunction, at least in part, through macrophage inflammasome-related signaling. Further analysis of a human cohort demonstrates that circulating SPARC protein levels are markedly elevated in patients with T2D, exhibiting a significant negative correlation with parameters indicative of insulin sensitivity and β-cell function, and a positive correlation with insulin resistance. Together, this work provides a systemic characterization of the effects of exercise intervention on islet homeostasis and β-cell function, and highlights SPARC as a candidate immuno-metabolic node for T2D intervention.
- 22 May 2026
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 53 (11) , 2084-2105
The development and application of deep learning for stem cell research
- 22 May 2026
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 53 (11) , 2084-2105
The development and application of deep learning for stem cell research
- Open Access
- 10 May 2026
- Published by Springer Nature in Cell & Bioscience
- Vol. 16 (1)
Investigation of embryogenesis in a dish: the development and application of gastruloid models from pluripotent stem cells
Gastrulation constitutes a critical phase of mammalian embryogenesis, during which the embryo undergoes morphological changes, germ layer determination, an
- 10 May 2026
- Published by Springer Nature in Cell & Bioscience
- Vol. 16 (1)
Open AccessInvestigation of embryogenesis in a dish: the development and application of gastruloid models from pluripotent stem cells
Gastrulation constitutes a critical phase of mammalian embryogenesis, during which the embryo undergoes morphological changes, germ layer determination, an
- Open Access
- 1 May 2026
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 3241 (1) , 012005
A high-efficiency intracellular delivery microfluidic chip toward gene editing
Intracellular delivery technology plays a pivotal role in biomedical fields such as drug delivery, gene therapy, and organ regeneration. Its efficiency and stability have always been the focus of researchers’ attention. With the continuous improvement in the preparation of nanodevices, microfluidic technology-based micro-nanochips have demonstrated great potential in intracellular delivery due to their advantages of low solvent consumption, high throughput, and high cell survival rate. However, conventional microfluidic chips still face numerous challenges in practical applications, including clogging, cell adhesion, and efficiency limitations. To address these issues, this study focuses on the structural design and preparation process optimization of microfluidic chips, and systematically analyzes the deformation of different types of droplets in the channels. The microfluidic chip achieves robust and scalable intracellular delivery, significantly avoiding clogging, inefficiency, and other issues, while maintaining high cell viability and significantly improving delivery efficiency. Experimental results show that the microfluidic chip designed in this study can achieve a transfection efficiency of over 92%, a cell survival rate of over 85%, and a high throughput of 3×10 5 cells/h. The findings of this study indicate that microfluidic chips, as emerging nanodevices, have broad application prospects in the biomedical field.
- 1 May 2026
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 3241 (1) , 012005
Open AccessA high-efficiency intracellular delivery microfluidic chip toward gene editing
Intracellular delivery technology plays a pivotal role in biomedical fields such as drug delivery, gene therapy, and organ regeneration. Its efficiency and stability have always been the focus of researchers’ attention. With the continuous improvement in the preparation of nanodevices, microfluidic technology-based micro-nanochips have demonstrated great potential in intracellular delivery due to their advantages of low solvent consumption, high throughput, and high cell survival rate. However, conventional microfluidic chips still face numerous challenges in practical applications, including clogging, cell adhesion, and efficiency limitations. To address these issues, this study focuses on the structural design and preparation process optimization of microfluidic chips, and systematically analyzes the deformation of different types of droplets in the channels. The microfluidic chip achieves robust and scalable intracellular delivery, significantly avoiding clogging, inefficiency, and other issues, while maintaining high cell viability and significantly improving delivery efficiency. Experimental results show that the microfluidic chip designed in this study can achieve a transfection efficiency of over 92%, a cell survival rate of over 85%, and a high throughput of 3×10 5 cells/h. The findings of this study indicate that microfluidic chips, as emerging nanodevices, have broad application prospects in the biomedical field.
- Open Access
- 24 December 2025
- Published by Springer Nature in Cell & Bioscience
- Vol. 16 (1)
Pluripotent stem cells-based neural organoids for modelling human brain development and diseases
Brain organoids have emerged as transformative in vitro models for studying human neurodevelopment, neural disorders, and evolutionary brain complexity. Th
- 24 December 2025
- Published by Springer Nature in Cell & Bioscience
- Vol. 16 (1)
Open AccessPluripotent stem cells-based neural organoids for modelling human brain development and diseases
Brain organoids have emerged as transformative in vitro models for studying human neurodevelopment, neural disorders, and evolutionary brain complexity. Th
- Open Access
- 26 May 2025
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 43 (7)
Transcriptomic analysis of the m6A reader YTHDF2 in the maintenance and differentiation of human embryonic stem cells
As the most abundant internal modification on mRNAs, N6-methyladenosine (m6A) has been discovered to be involved in different biological processes. Mostly determined by m6A methyl-transferases (m6A writers) and demethylases (m6A erasers), different cell types possess differential m6A profiles of transcriptomes. However, the interpretation of the m6A-encoded epitranscriptomic information needs m6A readers to bind and recruit different machinery for regulating the target mRNAs, which in turn, may regulate cell fates. The functions of the m6A readers in the regulation of the maintenance and differentiation of human embryonic stem cells (hESCs) remain largely unknown. In this study, we deleted the whole genomic region of the m6A reader YTHDF2 and discovered that YTHDF2 is dispensable for the maintenance, but important for the differentiation of hESCs, especially for the differentiation towards ectoderm. Furthermore, we identified the m6A-modified ROBO1 mRNAs as potential targets by YTHDF2 in regulating hESC to neuroectoderm differentiation. This study reveals the potential roles of the m6A reader YTHDF2 in regulating the specification of neuroectodermal cell fate.
- 26 May 2025
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 43 (7)
Open AccessTranscriptomic analysis of the m6A reader YTHDF2 in the maintenance and differentiation of human embryonic stem cells
As the most abundant internal modification on mRNAs, N6-methyladenosine (m6A) has been discovered to be involved in different biological processes. Mostly determined by m6A methyl-transferases (m6A writers) and demethylases (m6A erasers), different cell types possess differential m6A profiles of transcriptomes. However, the interpretation of the m6A-encoded epitranscriptomic information needs m6A readers to bind and recruit different machinery for regulating the target mRNAs, which in turn, may regulate cell fates. The functions of the m6A readers in the regulation of the maintenance and differentiation of human embryonic stem cells (hESCs) remain largely unknown. In this study, we deleted the whole genomic region of the m6A reader YTHDF2 and discovered that YTHDF2 is dispensable for the maintenance, but important for the differentiation of hESCs, especially for the differentiation towards ectoderm. Furthermore, we identified the m6A-modified ROBO1 mRNAs as potential targets by YTHDF2 in regulating hESC to neuroectoderm differentiation. This study reveals the potential roles of the m6A reader YTHDF2 in regulating the specification of neuroectodermal cell fate.